Brookline Capital Initiates Coverage On Genelux With Hold Rating, Announces Price Target of $25
Brookline Capital Initiates Coverage On Genelux With Hold Rating, Announces Price Target of $25
Brookline Capital以持有評級啓動對Genelux的報道,宣佈目標股價爲25美元
Brookline Capital analyst Kemp Dolliver initiates coverage on Genelux (NASDAQ:GNLX) with a Hold rating and announces Price Target of $25.
Brookline Capital分析師坎普·多利弗在Genelux(納斯達克代碼:GNLX)上以持有評級啟動覆蓋,並宣佈目標價為25美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。